Researchers report that, after ischemic stroke, the complement system identifies stressed but salvageable neurons for removal by microglial phagocytosis. To preserve these neurons, the investigators designed a novel therapeutic that targets a complement inhibitor to a damage signal expressed after stroke. A single post-stroke injection protected neurons from microglial attack in a preclinical model, reducing neuronal loss.